Cronos Group Inc (CRON)

[MrRhino]

Just the September 12th Article that you can click on the link below shows that they are a major player that doesn't need to make a bunch of noise.
And that they are putting One Foot In Front of the other knowing that slow and steady will win the race.

September 12, 2017
Cronos Receives Nasdaq International Designation
TORONTO, Sept. 12, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is pleased to announce that it is the first cannabis company to be admitted into the Nasdaq International Designation program under the symbol OTC – Nasdaq International Designation: PRMCF. This is an over-the-counter (OTC) platform designed for non-U.S. companies. The program provides member companies with Nasdaq’s visibility offering, allowing for greater access to U.S.-based investors.
“We’ve always had a strong U.S. investor base and that investor base continues to grow. This designation will improve Cronos’ visibility across U.S. capital markets and increase shareholder confidence and liquidity,” said Mike Gorenstein, CEO of Cronos.
Member companies of the Nasdaq International Designation are not listed or traded on The Nasdaq Stock Market, LLC. and are not subject to the same listing or qualification standards applicable to securities listed or traded on an exchange. The Company’s Nasdaq International Designation profile page can be found on http://business.nasdaq.com/list/International-Designation/cronos-group.html
About Cronos Group
Cronos Group is a geographically diversified and vertically integrated cannabis company that operates two wholly-owned Licensed Producers (“LPs”) regulated within Health Canada’s Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) and holds a portfolio of minority investments in other Licensed Producers. The Company’s flagship LPs, Peace Naturals Project Inc. (Ontario) and In The Zone Produce Ltd. (British Columbia), are collectively situated on over 125 acres of agricultural, licensed land. Cronos Group is focused on building an international iconic brand portfolio, providing patients with compassionate and personalized care, and creating value for our shareholders